|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 439.9 INR | +0.80% |
|
+0.03% | -20.57% |
| May. 10 | NetScientific says PDS Biotech's Versamune meets endpoints | AN |
| May. 10 | PDS Biotechnology Says Head, Neck Cancer Therapy Met Main Goal in Mid-Stage Study | MT |
Evrnu SPC announced that it will issue 12,317,721 series B preferred shares at issue price of $1.3431 per share for the gross proceeds $16,543,931.0751 in funding on October 6, 2021. The shares will be convertible in common shares at a fixed conversion price of $1.3431 per share. The round will be raised at post money valuation of $53,534,843.
The company will issue securities pursuant to exemption provided under Regulation D.
| 1st Jan change | Capi. | |
|---|---|---|
| +7.47% | 424B | |
| +4.59% | 144B | |
| -30.97% | 44.44B | |
| +13.90% | 18.47B | |
| +15.92% | 10.69B | |
| +36.76% | 9B | |
| +6.70% | 7.23B | |
| -6.64% | 6.58B | |
| +30.48% | 6.39B |
PDS LIMITED 
